有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | (2S)-N-(cyclododecylideneamino)-2-phenylsulfanylpropanamide | —— | C21H32N2OS |
|
—— | (4S)-3-propyl-4-(2-propylsulfanylpyrimidin-5-yl)-2,4,5,7-tetrahydropyrazolo[3,4-b]pyridin-6-one | —— | C16H21N5OS |
|
—— | (4R)-3-propyl-4-(2-propylsulfanylpyrimidin-5-yl)-2,4,5,7-tetrahydropyrazolo[3,4-b]pyridin-6-one | —— | C16H21N5OS |
|
—— | (2R)-N-(cyclododecylideneamino)-2-phenylsulfanylpropanamide | —— | C21H32N2OS |
|
—— | 2-propylsulfanyl-5-[[(3S)-3-(1H-pyrazol-5-yl)piperidin-1-yl]methyl]pyrimidine | —— | C16H23N5S |
|
—— | 2-propylsulfanyl-5-[[(3R)-3-(1H-pyrazol-5-yl)piperidin-1-yl]methyl]pyrimidine | —— | C16H23N5S |
|
—— | 2-[(4-benzyl-5-methyl-1,2,4-triazol-3-yl)sulfanyl]-N-[(1R,2R)-2-phenylcyclopropyl]acetamide | —— | C21H22N4OS |
|
—— | 2-[(4-benzyl-5-methyl-1,2,4-triazol-3-yl)sulfanyl]-N-[(1S,2S)-2-phenylcyclopropyl]acetamide | —— | C21H22N4OS |
|
—— | 2-[(4-benzyl-5-methyl-1,2,4-triazol-3-yl)sulfanyl]-N-[(1S,2R)-2-phenylcyclopropyl]acetamide | —— | C21H22N4OS |
|
—— | 5-Methyl-2-[(2-oxopropyl)sulfanyl]-6-(thiophen-2-yl)pyridine-3-carbonitrile | —— | C14H12N2OS2 |
|
—— | (2R)-1-[2-(2-methylpropyl)-5,7-dihydropyrrolo[3,4-d]pyrimidin-6-yl]-2-pyridin-2-ylsulfanylpropan-1-one | —— | C18H22N4OS |
|
—— | (4S)-6-methyl-N-[2-(1-methyltetrazol-5-yl)sulfanylethyl]-2-oxo-4-pyridin-3-yl-3,4-dihydro-1H-pyrimidine-5-carboxamide | —— | C15H18N8O2S |
|
—— | Ethyl 4-[1,4-dimethyl-5-[(3-methylphenyl)methyl]-6-oxopyrimidin-2-yl]sulfanylbutanoate | —— | C20H26N2O3S |
|
—— | (4R)-6-methyl-N-[2-(1-methyltetrazol-5-yl)sulfanylethyl]-2-oxo-4-pyridin-3-yl-3,4-dihydro-1H-pyrimidine-5-carboxamide | —— | C15H18N8O2S |
|
—— | (2S)-1-[2-(2-methylpropyl)-5,7-dihydropyrrolo[3,4-d]pyrimidin-6-yl]-2-pyridin-2-ylsulfanylpropan-1-one | —— | C18H22N4OS |
|
—— | (2R)-N-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-2-(4,6-dimethylpyrimidin-2-yl)sulfanyl-N-methylpropanamide | —— | C16H22N4O2S |
|
—— | (2S)-N-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-2-(4,6-dimethylpyrimidin-2-yl)sulfanyl-N-methylpropanamide | —— | C16H22N4O2S |
|
—— | 2-[[5-cyclohexyl-4-[(1S)-1-phenylethyl]-1,2,4-triazol-3-yl]sulfanyl]acetic acid | —— | C18H23N3O2S |
|
—— | (2S)-2-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]butanoic acid | —— | C7H11N3O2S |
|
—— | (5E)-5-{[5-(1H-benzimidazol-2-ylthio)-2-furyl]methylene}-3-isopropyl-1,3-thiazolidine-2,4-dione | —— | C18H15N3O3S2 |
|
—— | (2S)-2-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]butanoate | —— | C7H10N3O2S- |
|
—— | (2R)-2-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]butanoic acid | —— | C7H11N3O2S |
|
—— | 4-(4-Methyl-4H-[1,2,4]triazol-3-ylsulfanyl)-but-2-yn-1-ol | —— | C7H9N3OS |
|
—— | (1R,2R,3S,5R,7R)-2-[(S)-butylsulfinyl]-1,5-dimethyladamantane | —— | C16H28OS |
|
—— | (1R,2S,3S,5R,7R)-2-[(S)-butylsulfinyl]-1,5-dimethyladamantane | —— | C16H28OS |
|
—— | 4-{[5-(3-Bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl}but-2-yn-1-ol | —— | C12H9BrN2O2S |
|
—— | (2E,5Z)-3-(2-ethoxyethyl)-5-[4-(methylsulfanyl)benzylidene]-2-(phenylimino)-1,3-thiazolidin-4-one | —— | C21H22N2O2S2 |
|
—— | (3S)-3-amino-1-[[5-(1H-1,2,4-triazol-5-ylsulfanyl)furan-2-yl]methyl]pyrrolidine-3-carboxylic acid | —— | C12H15N5O3S |
|
—— | (3R)-3-amino-1-[[5-(1H-1,2,4-triazol-5-ylsulfanyl)furan-2-yl]methyl]pyrrolidine-3-carboxylic acid | —— | C12H15N5O3S |
|
—— | 1-[(1R)-1-isothiocyanatoethyl]adamantane | —— | C13H19NS |
|
—— | 1-[(3S)-3-phenyl-3,4-dihydropyrazol-2-yl]-2-[(4-phenyl-5-sulfanylidene-1,3,4-thiadiazol-2-yl)sulfanyl]ethanone | —— | C19H16N4OS3 |
|
—— | 1-[(1S)-1-isothiocyanatoethyl]adamantane | —— | C13H19NS |
|
—— | (3S)-N-[2-(1H-1,2,4-triazol-5-ylsulfanyl)ethyl]piperidin-3-amine | —— | C9H17N5S |
|
—— | (2S)-N-[(4-tert-butylcyclohexylidene)amino]-2-(4-methylphenyl)sulfanylpropanamide | —— | C20H30N2OS |
|
—— | (3R)-N-[2-(1H-1,2,4-triazol-5-ylsulfanyl)ethyl]piperidin-3-amine | —— | C9H17N5S |
|
—— | (4S)-4-[5-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]furan-2-yl]-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine | —— | C13H14N6OS |
|
—— | (4R)-4-[5-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]furan-2-yl]-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine | —— | C13H14N6OS |
|
—— | (5R)-2-[[5-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]furan-2-yl]methyl]-2,9-diazaspiro[4.5]decane | —— | C16H23N5OS |
|
—— | (5S)-2-[[5-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]furan-2-yl]methyl]-2,9-diazaspiro[4.5]decane | —— | C16H23N5OS |
|
—— | 2-[[4-methyl-5-(2-phenylethyl)-1,2,4-triazol-3-yl]sulfanyl]-N-[[(2S)-oxolan-2-yl]methyl]acetamide | —— | C18H24N4O2S |
|
—— | 2-[3-Cyano-6-(2-methylpropyl)pyridin-2-yl]sulfanyl-2-methylpropanoate | —— | C14H17N2O2S- |
|
—— | (2R)-N-[2-[(2-chloro-6-fluorophenyl)methylsulfanyl]ethyl]-2-(4-methylphenyl)sulfanylpropanamide | —— | C19H21ClFNOS2 |
|
—— | 2-[(5E)-5-[[4-(4-chlorophenyl)sulfanylphenyl]methylidene]-2,4-dioxo-1,3-thiazolidin-3-yl]acetate | —— | C18H11ClNO4S2- |
|
—— | (2S)-N-[2-[(2-chloro-6-fluorophenyl)methylsulfanyl]ethyl]-2-(4-methylphenyl)sulfanylpropanamide | —— | C19H21ClFNOS2 |
|
—— | [(5E)-5-{4-[(4-chlorophenyl)sulfanyl]benzylidene}-2,4-dioxo-1,3-thiazolidin-3-yl]acetic acid | —— | C18H12ClNO4S2 |
|
—— | (2R)-N-(2-tert-butylsulfanylethyl)-2-(4-methylphenyl)sulfanylpropanamide | —— | C16H25NOS2 |
|
—— | ethyl (2S)-2-(4,6-dimethylpyrimidin-2-yl)sulfanyl-2-phenylacetate | —— | C16H18N2O2S |
|
—— | (2S)-N-(2-tert-butylsulfanylethyl)-2-(4-methylphenyl)sulfanylpropanamide | —— | C16H25NOS2 |
|
—— | ethyl (2R)-2-(4,6-dimethylpyrimidin-2-yl)sulfanyl-2-phenylacetate | —— | C16H18N2O2S |
|
—— | (2R)-2-tert-butyl-2,3-dihydropyrido[1,2-b][1,4,2]oxathiazin-5-ium | —— | C11H16NOS+ |
|